MNPR
MNPR
US61023L2079
Monopar Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
529.99M EUR
621.48M EUR
367.04M EUR
437M EUR
Enterprise Value
429.59M EUR
568.83M EUR
314.63M EUR
375.32M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-41.22x
--
--
--
Price to Sales
--
--
--
--
Price to Book
4.05x
4.75x
2.71x
3.17x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.15%
-1.96%
-2.73%
-1.5%
ende